Skip to main content
News Icon

News categories: Honors & Funding

Metaflammation SFB being funded

The German Research Foundation is setting up a new Collaborative Research Center (SFB) at the University of Bonn. The SFB 1454 "Metaflammation and Cellular Programming" deals with the connection between a Western lifestyle and chronic inflammatory diseases - for example, how excessive calorie intake coupled with insufficient exercise can promote the development of cardiovascular diseases, neurodegenerative diseases or a metabolic syndrome.

The spokesperson is Prof. Dr. Eicke Latz, who is also spokesperson for ImmunoSensation2. The researchers use a holistic approach to investigate why lifestyle or environmental factors such as obesity, smoking or insufficient exercise influence the incorrect programming of immune cells and thus cause "metaflammation" - a chronic inflammation caused by the immune system.

The scientists are studying how cells interact in inflamed tissue and how molecular signaling pathways contribute to the development of diseases during metaflammation.

The SFB brings together the expertise of scientists from the Faculty of Medicine, the Faculty of Mathematics and Natural Sciences and the Faculty of Philosophy. Researchers from the German Center for Neurodegenerative Diseases (DZNE) in Bonn, the Max Planck Institute for Metabolic Research in Cologne and the "Braunschweig Integrated Center of Systems Biology" are also involved.

Most of the sub-projects of the new SFB are being carried out by scientists from the University Hospital Bonn and the Life and Medical Sciences Institute (LIMES).

"A unique selling point of our Collaborative Research Center is the system immunological approach with which we want to understand complex mechanisms that cause diseases," says Prof. Eicke Latz from the Institute for Innate Immunity at the University Hospital Bonn. On the one hand, these findings are intended to produce new therapeutic approaches and the development of drugs. On the other hand, the newly discovered mechanisms behind the development of metaflammation should provide the necessary knowledge to better prevent common diseases that can be traced back to an unhealthy lifestyle and environmental influences.


Contact

Prof. Dr. Eicke Latz

Institute of Innate Immunity

Phone: +49 (0)228 287 51239 (Secretary)

Eicke.Latz@uni-bonn.de

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview